Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Study links two ALS mechanisms

Nov. 2, 2020

"Foundational" research shows early gene therapy prevents Angelman syndrome

Oct. 30, 2020

New tool probes neurodevelopmental disorder genes

Oct. 29, 2020

Congenital hydrocephalus has significant genetic component

Oct. 29, 2020

New pilot study to evaluate afamelanotide for arterial ischemic stroke

Oct. 28, 2020

Alzheon studies ALZ-801 in phase II biomarker study for early Alzheimer's

Oct. 28, 2020

Positive 6-month interim analysis data presented from TOPAZ phase II study of SRK-015

Oct. 28, 2020

Prilenia initiates enrollment in phase III PROOF-HD trial of pridopidine

Oct. 28, 2020

Global phase III PolarisDMD trial of edasalonexent does not meet primary endpoint

Oct. 28, 2020

Interim data reported from phase I/II study of GTX-102 for Angelman syndrome

Oct. 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...